Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

NCT00497796 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

307

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Infections

Interventions

DRUG: maribavir
DRUG: ganciclovir

Sponsor

Shire